Stock Take 09/12/2021

Fitch downgrades Evergrande’s credit rating China Evergrande’s bankruptcy is becoming increasingly likely. The rating agency Fitch has further downgraded the highly indebted real estate giant. The experts now rate the creditworthiness of China’s second-largest property developer as “Restricted Default” (RD), which is the second-lowest level and is close to total default. The $300 billion indebted groups have defaulted on payments. …

Markets Update Thursday 09/12/2021 – Waiting for Friday

Frankfurt – 09/12/2021 Waiting for Friday The pre-Christmas stock rally has stopped for the time being. After three winning days in a row, the US stock markets ran out of steam. Concerns about measures needed to contain the new Corona variant Omikron dampened investor optimism. In addition, investors were cautious ahead of the US inflation data due on Friday. If …

Markets Update Wednesday 08/12/2021 – Between Hope and Evergrande

Frankfurt – 08/12/2021 Between Hope and Evergrande After the recent gains, Wall Street was quieter today. However, the Nasdaq technology exchange continued to be robust also because the Apple share continued its triumphant march. The corona variant Omikron remained the dominant topic on the stock exchange today. As later in New York, statements by the US pharmaceutical giant Pfizer and …

Markets Update Tuesday 07/12/2021 – Comeback

Frankfurt – 07/12/2021 Comeback The vigorous recovery of share prices on Wall Street at the beginning of the week continued on Tuesday. This is because worries about the economic consequences of a spread of the new Corona variant Omikron continue to ease in the USA. According to Anthony Fauci, Omikron is apparently no worse than other corona variants. “It is …

Markets Update Monday 06/12/2021 – Recovery

Frankfurt – 06/12/2021 Recovery The market’s current high volatility is still due to the recently reported corona mutation Omikron. Overall, there is still a lack of well-founded information on the virus, causing nervousness and uncertainty in the stock market. In addition, there are signs of an earlier than expected turnaround in interest rates in the USA.  According to market observers, …

Markets Update Friday 03/11/2021 – Bye

Frankfurt – 03/12/2021 Bye At the end of the week, a sell-off in technology stocks dampened sentiment on the US stock markets. Investors shied away from risk and sold stocks in light of the global spread of the corona mutation Omikron and high inflation.  Weaker-than-expected November labour market data had supported the stock market in early trading, pushing the Dow …

Markets Update Thursday 02/12/2021 – Nervous

Frankfurt – 02/12/2021 Nervous The vexed issue of the corona has once again taken hold of the markets and is unsettling investors. There is still a great deal of uncertainty both about the course of the disease at Omicron and about the effectiveness of the current vaccines and possible new restrictions for companies. And as we know, the stock market …

Markets Update Wednesday 01/12/2021 – Fear Markets

Frankfurt – 01/12/2021 Fear Markets While Omicron worries eased in Europe today, the first case in the USA unsettled Wall Street, the coronavirus variant thus continues to cause a lot of movement on the markets. In addition, it was Fed Chairman Powell who spooked investors again today. The old song of tapering-no-tapering had thus once again hurt prices on New …

Markets Update Tuesday 30/11/2021 – Back Down it goes

Frankfurt – 30/11/2021 Back Down it goes Statistically, November is one of the good stock market months. But in the grey “corona autumn”, everything is different this time. Due to the fear of new economic setbacks, the stock market month of November ended deeply in the red.  The warning by Moderna CEO Stephan Bancel caused uncertainty on the stock markets …

Markets Update Monday 29/11/2021 – Green Monday

Frankfurt – 29/11/2021 Green Monday After the sell-off on “Black Friday”, investors on Wall Street piled in at lower levels today. However, the DAX was unable to keep up on the Frankfurt Stock Exchange. Shares of vaccine manufacturers were in particular demand, which shows that the new Omikron variant was also very much a topic in New York. Moderna shares …